eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystic fibrosis |
| Symptom | |lung disease |
| Sentences | 65 |
| PubMedID- 25725986 | Background: although recent studies have begun to elucidate how airway microbial community structure relates to lung disease in cystic fibrosis (cf), microbial community activity and the host's response to changes in this activity are poorly understood. |
| PubMedID- 26453627 | Further issues that require attention are organ transplantation and end of life management.lung disease in adults with cystic fibrosis drives most of the clinical care requirements, and major life-threatening complications, such as respiratory infection, respiratory failure, pneumothorax and haemoptysis, and the management of lung transplantation require expertise from trained respiratory physicians. |
| PubMedID- 23235684 | Authors' conclusions: this review did not find any evidence for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis. |
| PubMedID- 23378408 | Hrct has an advantage over conventional chest x-rays in the evaluation of the stage and progression of lung disease in patients with cystic fibrosis. |
| PubMedID- 26383963 | Association of chronic candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis. |
| PubMedID- 21462361 | Genetic studies of lung disease in cystic fibrosis (cf) are hampered by the lack of a severity measure that accounts for chronic disease progression and mortality attrition. |
| PubMedID- 25984165 | Recent data indicate that azithromycin is beneficial in lung disease of cystic fibrosis because it directly suppresses excessive inflammation 3. |
| PubMedID- 22497648 | We report a 29 year old male cystic fibrosis patient with end stage lung disease and normal renal function who underwent a sequential double lung transplant. |
| PubMedID- 23272037 | It is known that low doses of dexamethasone slow the progression of lung disease in patients with cystic fibrosis through its role in reducing the inflammation associated with the bacterial infection . |
| PubMedID- 25470304 | Authors' conclusions: this review did not find any evidence for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis. |
| PubMedID- 20427819 | The development of lung disease in cystic fibrosis pigs. |
| PubMedID- 25222938 | Pulmonary hypertension in cystic fibrosis with advanced lung disease. |
| PubMedID- 20634941 | Most of the morbidity and mortality of cystic fibrosis patients results from the lung disease 3. |
| PubMedID- 25929952 | Percentages of airway cxcr4(+) granulocytes correlated with lung disease severity in patients with cystic fibrosis.these studies demonstrate that chronic fungal colonisation with a. |
| PubMedID- 20811560 | Tuberculosis, including tuberculosis bronchiectasis, bronchogenic carcinoma, and chronic inflammatory lung disease due to bronchiectasis, cystic fibrosis, or aspergillosis are the most common causes of massive hemoptysis . |
Page: 1 2